Combination of Infliximab and High-Dose Intravenous Immunoglobulin for Toxic Epidermal Necrolysis: Successful Treatment of an Elderly Patient

• Main Authors: Konstantinos Patmanidis (Author), Anastasios Sidiras (Author), Konstantinos Dolianitis (Author), Dimitrios Simelidis (Author), Christos Solomonidis (Author), Georgios Gaitanis (Author), Ioannis D. Bassukas (Author)
• Format: Book
• Published: Hindawi Limited, 2012-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Toxic epidermal necrolysis (TEN) is a rare, severe cutaneous adverse drug reaction with average mortality 25-35%, especially among elderly multimorbid patients. Established therapeutic guidelines do not exist and controversies underlie many of the presently suggested treatment regimens. Herein we pr...